Ibrutinib and Netupitant: Interaction Details

Brand names
Ibrutinib
Imbruvica
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Netupitant

We don't have a separate drug information page for Netupitant. The FDA's drug directory lists it as part of Akynzeo (netupitant and palonosetron). Read the Netupitant and Palonosetron drug information page → Have a question about Netupitant? Ask a pharmacist, free →

What Happens When You Take Ibrutinib With Netupitant

What can happen when they are taken together (rated Major)

Increased ibrutinib exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

In a study, giving erythromycin (a moderate ) together with ibrutinib raised steady-state ibrutinib exposure roughly 3-fold. When a moderate CYP3A inhibitor must be used with ibrutinib, patients should be watched closely for ibrutinib toxicity, and the dose should be adjusted according to the condition for which ibrutinib is given.

Adults with B-cell malignancies should have ibrutinib lowered to 280 mg/day. In chronic graft versus host disease, the starting ibrutinib dose is 420 mg/day for patients aged 12 years or older, or 240 mg/m(2) for those aged 1 to less than 12 years.

For every patient, the dose should be changed as needed in response to adverse reactions. Once the CYP3A inhibitor has been stopped, ibrutinib should be returned to the prior dose.1

The Ibrutinib and Netupitant Interaction, Explained

Netupitant is an anti-nausea medicine (it comes combined with palonosetron as Akynzeo) often used around chemotherapy. Ibrutinib (Imbruvica) is used for certain blood cancers and for chronic graft versus host disease. Netupitant can slow down , a liver enzyme that helps break down ibrutinib, so more ibrutinib may stay in your body. That could raise the chance of side effects such as bleeding, infections, or irregular heartbeat.

This is based on how the drugs are expected to work, and a similar drug (erythromycin) raised ibrutinib levels about 3-fold. The good news is your care team can manage it by adjusting your ibrutinib dose and watching you more closely. Please don't change anything on your own. Check with your pharmacist or doctor.

Mechanism: Netupitant is a moderate . Ibrutinib is extensively cleared by , so is expected to increase ibrutinib exposure (higher /). Evidence for this specific pair is theoretical, extrapolated from erythromycin (moderate CYP3A inhibitor), which increased steady-state ibrutinib exposure about 3-fold. Onset is unspecified.

  • B-cell malignancies (adults): reduce ibrutinib to 280 mg/day.
  • cGVHD: start 420 mg/day (12 years or older) or 240 mg/m² (1 to under 12 years).
  • Monitor closely for ibrutinib toxicity (bleeding, infection, , cytopenias) and modify the dose for adverse reactions.
  • After the CYP3A inhibitor is stopped, resume the previous ibrutinib dose.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Ibrutinib and Netupitant Interact

The likely mechanism

of -mediated ibrutinib

In short: Netupitant slows CYP3A, an enzyme that breaks down ibrutinib, so ibrutinib can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Ibrutinib and Netupitant Interaction

Your care team can manage this by tailoring your ibrutinib dose and monitoring you more closely.

  • Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
  • Your team may lower your ibrutinib dose while you take netupitant. The dose depends on why you take ibrutinib (a B-cell cancer or chronic graft versus host disease).
  • Your dose may be further adjusted if side effects occur.
  • When netupitant is stopped, your team will typically return you to your previous ibrutinib dose.
  • Tell your pharmacist or prescriber about any unusual bleeding, bruising, infection signs, or heart palpitations.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Ibrutinib or Netupitant need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: IMBRUVICA oral capsules, ibrutinib oral capsules

    When multiple doses of erythromycin (a moderate ) were given together with ibrutinib, steady-state ibrutinib rose 3.4-fold and rose 3-fold.2

Ibrutinib and Netupitant: Common Questions

How serious is the Ibrutinib and Netupitant interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Ibrutinib and Netupitant interaction managed?

Your care team can manage this by tailoring your ibrutinib dose and monitoring you more closely. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your team may lower your ibrutinib dose while you take netupitant. The dose depends on why you take ibrutinib (a B-cell cancer or chronic graft versus host disease). Your dose may be further adjusted if side effects oc… Management is individual — always follow your own care team's guidance.

Does taking Ibrutinib and Netupitant at different times of day help?

No. Taking them at different times of day does not prevent this one. Netupitant slows , an enzyme that breaks down ibrutinib, so ibrutinib can build up in the body. That change lasts while netupitant is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Ibrutinib and Netupitant Interaction

Ask in your own words about taking Ibrutinib and Netupitant together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: IMBRUVICA(R) oral capsules, oral tablets, oral suspension, ibrutinib oral capsules, oral tablets, oral suspension. Pharmacyclics LLC (per FDA), South San Francisco, CA, 2022. DailyMed
  2. Product Information: IMBRUVICA(R) oral capsules, ibrutinib oral capsules. Pharmacyclics LLC (per FDA), Sunnyvale, CA, 2017. DailyMed
Was this write-up helpful?

Other Serious Interactions of Ibrutinib and Netupitant

Also serious with Netupitant

Also serious with Ibrutinib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Ibrutinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.